Search Within

Maria Theodoulou-Haber

Formats
  1. Meeting Abstract (33)
  2. Journal Article (31)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (63)
  2. Solid Tumor Oncology Division (63)
  3. Breast Medicine Service (60)
  4. Survivorship Research (58)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (48)
  6. Epidemiology and Biostatistics (30)

More Groups

People
  1. Clifford Hudis (58)
  2. Larry Norton (45)
  3. Gabriella D'Andrea-Carlino (25)
  4. Tiffany Traina (23)
  5. Andrew Seidman (22)
  6. Monica Fornier (22)

More People

Years
  1. 2019 (1)
  2. 2016 (1)
  3. 2015 (2)
  4. 2014 (2)
  5. 2013 (3)
  6. 2012 (5)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Breast Cancer Research and Treatment (8)
  3. Cancer Research (6)
  4. Clinical Breast Cancer (5)
  5. Clinical Cancer Research (5)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. American Association for Cancer Research (11)
  3. Elsevier Inc. (9)
  4. Springer (8)
  5. Wiley Blackwell (5)
  6. Informa Healthcare (2)

More Publishers

Results (66)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized trial of standard adjuvant chemotherapy regimens versus capecitabine in older women with early breast cancer: 10-year update of the CALGB 49907 trial
    Journal Article

    Muss, H. B.; Polley, M. Y. C.; Berry, D. A.; Liu, H.; Cirrincione, C. T.; Theodoulou, M.; Mauer, A. M.; Kornblith, A. B.; Partridge, A. H.; Dressler, L. G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer
    Journal Article

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • Standard chemotherapy versus capcitabine for older women with early stage breast cancer: An update of CALGB/CTSU/Alliance 49907
    Meeting Abstract

    Muss, H. B.; Berry, D. A.; Cirrincione, C. T.; Theodoulou, M.; Hurria, A.; Cohen, H. J.; Partridge, A.; Norton, L.; Hudis, C. A.; Winer, E. P.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Shah, P. D.; Charen, A. S.; Bromberg, J.; Comen, E. A.; D'Andrea, G.; Dang, C. T.; Gilewski, T.; Gucalp, A.; Lake, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Effect of renal function (RF) on outcomes in the adjuvant treatment of older women with breast cancer (> 65 years): CALGB/CTSU 49907 (CC) ancillary data study
    Meeting Abstract

    Lichtman, S. M.; Cirrincione, C.; Hurria, A.; Jatoi, A.; Theodoulou, M.; Wolff, A. C.; Gralow, J.; Morganstern, D.; Magrinat, G.; Cohen, H. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
    Meeting Abstract

    Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Theodoulou, M.; Goldfarb, S. B.; Lake, D.; Fornier, M. N.; Modi, S.; Sklarin, N. T.; Comen, E. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save